AI-based next-generation anonymization technology developed in Finland enables versatile and high-quality research utilization of health data. Bayer, a pharmaceutical
In the world of Nordic entrepreneurship, VEIL.AI was selected to join the elite Nordic Mentor Network for Entrepreneurship (NOME)
VEIL.AI, the most experienced European health tech company in health data anonymization, has announced a new addition to their
Drug development is a laborious, time-consuming process. On average, developing a new drug takes 10 years – about seven
Why is integrating health data from multiple sources important? The future of medicine is built on data, with an
The BioInnovation Institute (BII), an international commercial non-profit foundation incubating and accelerating world-class life science research, today announces its
Welcome to meet us at HIMSS (booth 814) to hear how next generation anonymization technology brings the quality of
“…It is important to get moving on your data-driven journey…” Data is becoming more important for pharmaceutical companies every
An international project Future Clinical Trials being implemented in Finland aims to speed up drug research and increase safety.
MediSapiens and VEIL.AI (Helsinki, Finland) are excited to announce their cooperation in launching an innovative process for the anonymization
